CXCR1/CXCR2 inhibitor (Theracrine)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCXCR1/CXCR2 inhibitor (Theracrine)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 1 antagonistsC-X-C motif chemokine receptor 2 antagonists
TargetsC-X-C motif chemokine receptor 1C-X-C motif chemokine receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheracrine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheracrine Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A